sodium picosulfate

Reduced efficacy of sodium picosulfate, leading to inadequate bowel preparation or constipation.

Consider alternative bowel preparation regimens or adjust the timing of antibiotic administration if possible. Monitor for adequate bowel cleansing. If used for chronic constipation, monitor for reduced laxative effect.

Increased risk of severe hypokalemia, which can lead to muscle weakness, cardiac arrhythmias, and other complications.

Monitor serum potassium levels closely before and after sodium picosulfate administration, especially in patients receiving corticosteroids. Ensure adequate potassium supplementation if necessary.

Increased risk of digoxin toxicity (e.g., arrhythmias, nausea, visual disturbances).

Monitor serum potassium and other electrolytes closely before and after sodium picosulfate administration, especially in patients on digoxin. Consider temporary discontinuation of digoxin or close cardiac monitoring if electrolyte disturbances are severe.

Increased risk of severe dehydration, hypokalemia, hyponatremia, and other electrolyte disturbances, potentially leading to cardiac arrhythmias or renal impairment.

Monitor fluid and electrolyte status (potassium, sodium, magnesium, calcium) closely before, during, and after sodium picosulfate administration. Ensure adequate hydration. Consider temporary discontinuation or dose adjustment of diuretics if clinically indicated.

Increased risk of serious ventricular arrhythmias, including Torsades de Pointes.

Monitor serum electrolytes (potassium, magnesium) closely before and after sodium picosulfate administration. Correct any electrolyte imbalances promptly. Consider ECG monitoring in high-risk patients.

Increased risk of lithium toxicity (e.g., tremor, confusion, ataxia, seizures).

Monitor serum lithium levels closely before and after sodium picosulfate administration. Ensure adequate hydration. Adjust lithium dose as necessary. Monitor fluid and electrolyte status.

Increased risk of acute kidney injury, especially in elderly patients, those with pre-existing renal impairment, or those on other nephrotoxic drugs.

Ensure adequate hydration before and after sodium picosulfate administration. Monitor renal function (creatinine, BUN) closely, especially in patients at risk. Consider temporary discontinuation of NSAIDs if clinically feasible.

Reduced efficacy of sodium picosulfate, leading to inadequate bowel preparation or severe constipation.

Monitor for adequate bowel cleansing. If used for chronic constipation, higher doses of sodium picosulfate or additional laxatives may be required. Consider alternative bowel preparation regimens if opioid use is ongoing.

Reduced efficacy of oral contraceptives, leading to an increased risk of unintended pregnancy.

Advise patients to use an additional, reliable barrier method of contraception during and for at least 7 days after taking sodium picosulfate. This is particularly relevant when sodium picosulfate is used for bowel preparation.

Reduced efficacy of sodium picosulfate, leading to inadequate bowel preparation or constipation.

Monitor for adequate bowel cleansing. If used for chronic constipation, monitor for reduced laxative effect and consider alternative laxatives or dose adjustments if necessary.

Reduced efficacy of iron supplementation.

Separate administration times by several hours if possible. If sodium picosulfate is used for bowel preparation, temporary interruption of iron supplements may be considered.

Reduced efficacy of thyroid hormone replacement, potentially leading to hypothyroidism.

Separate administration times by several hours if possible. Monitor thyroid function tests if sodium picosulfate is used frequently or for prolonged periods.